A Phase 1 Open-Label, Single-Dose, Dose Escalation Study in Healthy Subjects to Evaluate the Safety and Pharmacokinetics of Orally Administered Civamide (Zucapsaicin).
Phase of Trial: Phase I
Latest Information Update: 09 Jun 2011
At a glance
- Drugs Zucapsaicin (Primary)
- Indications Cluster headache; Migraine; Musculoskeletal pain; Postherpetic neuralgia
- Focus Pharmacokinetics
- Sponsors Winston Laboratories
- 16 Jun 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 24 Apr 2009 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Apr 2009 Planned end date changed from 1 Feb 2009 to 1 Jul 2009 as reported by ClinicalTrials.gov.